Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 61

1.

APPE Evaluations are Positively Associated with MMI, Pre-pharmacy GPA and Pharmacy GPA.

Heldenbrand SD, Dayer LE, Martin BC, O'Brien C, Choi AN, Gubbins PO, Hawthorne J, Ramey M, Willis K, Flowers SK.

Am J Pharm Educ. 2018 Sep;82(7):6326. doi: 10.5688/ajpe6326.

2.

Pharmacogenomics of triazole antifungal agents: implications for safety, tolerability and efficacy.

Amsden JR, Gubbins PO.

Expert Opin Drug Metab Toxicol. 2017 Nov;13(11):1135-1146. doi: 10.1080/17425255.2017.1391213. Epub 2017 Oct 20. Review.

PMID:
29022838
3.

Assessing the Medication Adherence App Marketplace From the Health Professional and Consumer Vantage Points.

Dayer LE, Shilling R, Van Valkenburg M, Martin BC, Gubbins PO, Hadden K, Heldenbrand S.

JMIR Mhealth Uhealth. 2017 Apr 19;5(4):e45. doi: 10.2196/mhealth.6582.

4.

Potential for Pharmacy-Public Health Collaborations Using Pharmacy-Based Point-of-Care Testing Services for Infectious Diseases.

Gubbins PO, Klepser ME, Adams AJ, Jacobs DM, Percival KM, Tallman GB.

J Public Health Manag Pract. 2017 Nov/Dec;23(6):593-600. doi: 10.1097/PHH.0000000000000482. Review.

PMID:
27997479
5.

Multiple Mini-Interview Performance Predicts Academic Difficulty in the PharmD Curriculum.

Heldenbrand SD, Flowers SK, Bordelon BJ, Gubbins PO, O'Brien C, Stowe CD, Martin BC.

Am J Pharm Educ. 2016 Mar 25;80(2):27. doi: 10.5688/ajpe80227.

6.

Exploration of Methods Used by Pharmacy Professional Programs to Contract with Experiential Practice Sites.

Brownfield A, Garavalia L, Gubbins PO, Ruehter V.

Am J Pharm Educ. 2016 Mar 25;80(2):26. doi: 10.5688/ajpe80226.

7.

Assessment of medication adherence app features, functionality, and health literacy level and the creation of a searchable Web-based adherence app resource for health care professionals and patients.

Heldenbrand S, Martin BC, Gubbins PO, Hadden K, Renna C, Shilling R, Dayer L.

J Am Pharm Assoc (2003). 2016 May-Jun;56(3):293-302. doi: 10.1016/j.japh.2015.12.014. Epub 2016 Apr 7.

PMID:
27067551
8.

Family Commitment and Work Characteristics among Pharmacists.

Gubbins PO, Ragland D, Castleberry AN, Payakachat N.

Pharmacy (Basel). 2015 Dec 17;3(4):386-398. doi: 10.3390/pharmacy3040386.

9.

The Influence of Influenza and Pneumococcal Vaccines on Community-Acquired Pneumonia (CAP) Outcomes Among Elderly Patients.

Gubbins PO, Li C.

Curr Infect Dis Rep. 2015 Dec;17(12):49. doi: 10.1007/s11908-015-0505-6.

PMID:
26446610
10.

Prior pneumococcal and influenza vaccinations and in-hospital outcomes for community-acquired pneumonia in elderly veterans.

Li C, Gubbins PO, Chen GJ.

J Hosp Med. 2015 May;10(5):287-93. doi: 10.1002/jhm.2328. Epub 2015 Feb 13.

PMID:
25676363
11.

Innovation in clinical pharmacy practice and opportunities for academic--practice partnership.

Gubbins PO, Micek ST, Badowski M, Cheng J, Gallagher J, Johnson SG, Karnes JH, Lyons K, Moore KG, Strnad K.

Pharmacotherapy. 2014 May;34(5):e45-54.

PMID:
24877189
12.

To the Editor.

Dering-Anderson A, Gubbins PO, Klepser D, Klepser M.

Am J Pharm Educ. 2014 Mar 12;78(2):42. No abstract available.

PMID:
24796029
13.

The need for PGY2-trained clinical pharmacy specialists.

Ragucci KR, O'Bryant CL, Campbell KB, Buck ML, Dager WE, Donovan JL, Emerson K, Gubbins PO, Haight RJ, Jackevicius C, Murphy JE, Prohaska E.

Pharmacotherapy. 2014 Jun;34(6):e65-73. doi: 10.1002/phar.1430. Epub 2014 Apr 18.

PMID:
24752824
14.

Point-of-care testing for infectious diseases: opportunities, barriers, and considerations in community pharmacy.

Gubbins PO, Klepser ME, Dering-Anderson AM, Bauer KA, Darin KM, Klepser S, Matthias KR, Scarsi K.

J Am Pharm Assoc (2003). 2014 Mar-Apr;54(2):163-71. doi: 10.1331/JAPhA.2014.13167. Review.

PMID:
24632931
15.

Factors associated with health-related quality of life of student pharmacists.

Payakachat N, Gubbins PO, Ragland D, Flowers SK, Stowe CD.

Am J Pharm Educ. 2014 Feb 12;78(1):7. doi: 10.5688/ajpe7817.

16.

Smartphone medication adherence apps: potential benefits to patients and providers: response to Aungst.

Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC.

J Am Pharm Assoc (2003). 2013 Jul-Aug;53(4):345. doi: 10.1331/JAPhA.2013.13121. No abstract available.

PMID:
23892801
17.

Steady-state pharmacokinetics of oral voriconazole and its primary metabolite, N-oxide voriconazole, pre- and post-autologous peripheral stem cell transplantation.

Amsden JR, Gubbins PO, McConnell S, Anaissie E.

Antimicrob Agents Chemother. 2013 Jul;57(7):3420-3. doi: 10.1128/AAC.00046-13. Epub 2013 Apr 29.

18.

Smartphone medication adherence apps: potential benefits to patients and providers.

Dayer L, Heldenbrand S, Anderson P, Gubbins PO, Martin BC.

J Am Pharm Assoc (2003). 2013 Mar-Apr;53(2):172-81. doi: 10.1331/JAPhA.2013.12202.

19.

Academic help-seeking behavior among student pharmacists.

Payakachat N, Gubbins PO, Ragland D, Norman SE, Flowers SK, Stowe CD, DeHart RM, Pace A, Hastings JK.

Am J Pharm Educ. 2013 Feb 12;77(1):7. doi: 10.5688/ajpe7717.

20.

Triazole antifungal agents drug-drug interactions involving hepatic cytochrome P450.

Gubbins PO.

Expert Opin Drug Metab Toxicol. 2011 Nov;7(11):1411-29. doi: 10.1517/17425255.2011.627854. Epub 2011 Oct 13. Review.

PMID:
21995615
21.

Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis.

Bariola JR, Hage CA, Durkin M, Bensadoun E, Gubbins PO, Wheat LJ, Bradsher RW Jr.

Diagn Microbiol Infect Dis. 2011 Feb;69(2):187-91. doi: 10.1016/j.diagmicrobio.2010.09.015.

PMID:
21251563
22.

Benchmarking in academic pharmacy departments.

Bosso JA, Chisholm-Burns M, Nappi J, Gubbins PO, Ross LA.

Am J Pharm Educ. 2010 Oct 11;74(8):140.

23.

Clinically relevant drug interactions of current antifungal agents.

Gubbins PO, Heldenbrand S.

Mycoses. 2010 Mar 1;53(2):95-113. doi: 10.1111/j.1439-0507.2009.01820.x. Epub 2009 Dec 11. Review.

PMID:
20002883
24.

Population mobility, globalization, and antimicrobial drug resistance.

MacPherson DW, Gushulak BD, Baine WB, Bala S, Gubbins PO, Holtom P, Segarra-Newnham M.

Emerg Infect Dis. 2009 Nov;15(11):1727-32. Review.

26.

Examining sex-related differences in enteric itraconazole metabolism in healthy adults using grapefruit juice.

Gubbins PO, Gurley BJ, Williams DK, Penzak SR, McConnell SA, Franks AM, Saccente M.

Eur J Clin Pharmacol. 2008 Mar;64(3):293-301. doi: 10.1007/s00228-007-0417-y. Epub 2008 Jan 3.

PMID:
18172627
27.

Mould-active azoles: pharmacokinetics, drug interactions in neutropenic patients.

Gubbins PO.

Curr Opin Infect Dis. 2007 Dec;20(6):579-86. Review.

PMID:
17975407
28.

Clinical research in the lay press: irresponsible journalism raises a huge dose of doubt.

Anaissie EJ, Segal BH, Graybill JR, Arndt C, Perfect JR, Kleinberg M, Pappas P, Benjamin D, Rubin R, Aberg JA, Adderson EE, Adler-Shohet FC, Akan H, Akova M, Almyroudis NG, Alexander BD, Andes D, Arrieta A, Baddley JW, Barron MA, Belzberg H, Boucher HW, Boyce TG, Casadevall A, Chandrasekar PH, Cleary JD, Cordonnier C, Cornely OA, Cuenca-Estrella M, Daly JS, Daoura N, Denning DW, dePauw B, de Repentigny L, Dignani MC, Dismukes WE, Donnelly JP, Donowitz GR, Dupont B, Drusano G, Ellis M, Espinel-Ingroff A, Fishman JA, Fleming R, Forrest G, Ghannoum M, Goldman M, Grazziutti M, Greene JN, Greenberg RN, Gubbins PO, Hadley S, Herbrecht R, Hiemenz JW, Hope W, Hospenthal DR, Husain S, Ito JI, Jacobson RM, Johnson M, Keating MR, Kett DH, Knapp K, Kontoyiannis DP, Krcmery VC, Larsen R, Laverdiere M, Ljungman P, Lortholary O, Maertens J, Marriott D, Mattiuzzi G, McGinnis MR, Morris M, Nucci M, Odds FC, Pankey GA, Patterson T, Pfaller M, Razonable RR, Reboli AC, Rinaldi MG, Roberts GD, Rodriguez Tudela JL, Rotstein C, Ruhnke M, Schuster M, Shoham S, Sia IG, Siebel N, Silviera F, Singh N, Sobel J, Solomkin JS, Sorrell TC, Steinbach WJ, Temesgen Z, Tortorano A, Vartivarian S, VerWeij P, Viscoli C, Viviani MA, Walker RC, Wheat JL, Wiley J, Williamson P, Wingard JR, Yu VL, Zaoutis T.

Clin Infect Dis. 2006 Oct 15;43(8):1031-9. Epub 2006 Sep 13. No abstract available. Erratum in: Clin Infect Dis. 2007 Mar 15;44(6):894.

PMID:
16983616
29.

Pharmacokinetics and safety of oral posaconazole in neutropenic stem cell transplant recipients.

Gubbins PO, Krishna G, Sansone-Parsons A, Penzak SR, Dong L, Martinho M, Anaissie EJ.

Antimicrob Agents Chemother. 2006 Jun;50(6):1993-9.

30.

Drug-drug interactions of antifungal agents and implications for patient care.

Gubbins PO, Amsden JR.

Expert Opin Pharmacother. 2005 Oct;6(13):2231-43. Review.

PMID:
16218884
31.

Tick-borne bacterial, rickettsial, spirochetal, and protozoal infectious diseases in the United States: a comprehensive review.

Amsden JR, Warmack S, Gubbins PO.

Pharmacotherapy. 2005 Feb;25(2):191-210. Review.

PMID:
15767235
32.

Are antimicrobial-impregnated catheters effective? Replace the water and grab your washcloth, because we have a baby to wash.

McConnell SA, Gubbins PO, Anaissie EJ.

Clin Infect Dis. 2004 Dec 15;39(12):1829-33. Epub 2004 Nov 19.

PMID:
15578407
33.

Renal interaction between itraconazole and cimetidine.

Karyekar CS, Eddington ND, Briglia A, Gubbins PO, Dowling TC.

J Clin Pharmacol. 2004 Aug;44(8):919-27.

PMID:
15286096
34.

Influence of grapefruit juice on the systemic availability of itraconazole oral solution in healthy adult volunteers.

Gubbins PO, McConnell SA, Gurley BJ, Fincher TK, Franks AM, Williams DK, Penzak SR, Saccente M.

Pharmacotherapy. 2004 Apr;24(4):460-7.

PMID:
15098799
35.

Do antimicrobial-impregnated central venous catheters prevent catheter-related bloodstream infection?

McConnell SA, Gubbins PO, Anaissie EJ.

Clin Infect Dis. 2003 Jul 1;37(1):65-72. Epub 2003 Jun 24. Review.

PMID:
12830410
36.

Evaluation of P-glycoprotein-mediated renal drug interactions in an MDR1-MDCK model.

Karyekar CS, Eddington ND, Garimella TS, Gubbins PO, Dowling TC.

Pharmacotherapy. 2003 Apr;23(4):436-42.

PMID:
12680473
37.

Effect of interleukin 6 on the hepatic metabolism of itraconazole and its metabolite hydroxyitraconazole using primary human hepatocytes.

Gubbins PO, Melchert RB, McConnell SA, Franks AM, Penzak SR, Gurley BJ.

Pharmacology. 2003 Apr;67(4):195-201.

PMID:
12595750
38.

Characterizing and predicting amphotericin B-associated nephrotoxicity in bone marrow or peripheral blood stem cell transplant recipients.

Gubbins PO, Penzak SR, Polston S, McConnell SA, Anaissie E.

Pharmacotherapy. 2002 Aug;22(8):961-71.

PMID:
12173799
39.

Rapid and sensitive high-performance liquid chromatographic method for the determination of ritonavir in human plasma.

Penzak SR, Lawhorn WD, Gubbins PO.

Int J Clin Pharmacol Ther. 2001 Sep;39(9):400-5.

PMID:
11563687
40.

Incidence of imipenem hypersensitivity reactions in febrile neutropenic bone marrow transplant patients with a history of penicillin allergy.

McConnell SA, Penzak SR, Warmack TS, Anaissie EJ, Gubbins PO.

Clin Infect Dis. 2000 Dec;31(6):1512-4.

PMID:
11096026
41.

Investigation of an outbreak of gram-negative bacteremia among hematology-oncology outpatients.

Penzak SR, Gubbins PO, Stratton SL, Anaissie EJ.

Infect Control Hosp Epidemiol. 2000 Sep;21(9):597-9.

PMID:
11001264
42.

Current management of funguria.

Gubbins PO, McConnell SA, Penzak SR.

Am J Health Syst Pharm. 1999 Oct 1;56(19):1929-35; quiz 1936. Review.

PMID:
10554910
43.

Grapefruit juice decreases the systemic availability of itraconazole capsules in healthy volunteers.

Penzak SR, Gubbins PO, Gurley BJ, Wang PL, Saccente M.

Ther Drug Monit. 1999 Jun;21(3):304-9.

PMID:
10365642
44.

Therapeutic drug monitoring of vancomycin in a morbidly obese patient.

Penzak SR, Gubbins PO, Rodvold KA, Hickerson SL.

Ther Drug Monit. 1998 Jun;20(3):261-5.

PMID:
9631922
45.

Antifungal prophylaxis to prevent invasive mycoses among bone marrow transplantation recipients.

Gubbins PO, Bowman JL, Penzak SR.

Pharmacotherapy. 1998 May-Jun;18(3):549-64. Review.

PMID:
9620106
46.
47.

The association between cryptococcal variety and immunocompetent and immunocompromised hosts.

Peachey PR, Gubbins PO, Martin RE.

Pharmacotherapy. 1998 Mar-Apr;18(2):255-64. Review.

PMID:
9545144
48.

Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.

Penzak SR, Gubbins PO.

Am J Health Syst Pharm. 1998 Feb 1;55(3):279-83. Review. No abstract available.

PMID:
9492260
49.

Relative bioavailability of itraconazole from an extemporaneously prepared suspension and from the marketed capsules.

Christensen KJ, Gubbins PO, Gurley BJ, Bowman JL, Buice RG.

Am J Health Syst Pharm. 1998 Feb 1;55(3):261-5.

PMID:
9492256
50.

More on mechanisms of bacterial resistance.

Penzak SR, Gubbins PO, McManus C.

Am J Health Syst Pharm. 1997 Dec 1;54(23):2744, 2747-8. No abstract available.

PMID:
9408522

Supplemental Content

Loading ...
Support Center